A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells

scientific article published on 01 February 2020

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD.2019001859
P698PubMed publication ID31703119

P50authorCarl H. JuneQ19277113
Marco RuellaQ56947896
Simon F LaceyQ56978267
Avery D. PoseyQ110798824
P2093author name stringOlga Shestova
David M Barrett
J Joseph Melenhorst
Miroslaw Kozlowski
Seok Jae Hong
Saar I Gill
Jessica Perazzelli
P433issue7
P304page(s)505-509
P577publication date2020-02-01
P1433published inBloodQ885070
P1476titleA cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells
P478volume135

Reverse relations

cites work (P2860)
Q90479721Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review
Q104795247Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch

Search more.